Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > New Investor Presentation

<< Previous

Bullboard Posts

Next >>

Post by Pareto8020on Mar 02, 2024 9:28am

240 Views

Post# 35910991

New Investor Presentation

Well they finally updated it....

https://www.sironabiochem.com/wp-content/uploads/2024/02/Sirona-Biochem-Corporate-Deck-with-Sirona-Labs-Product-Line-Feb-1-2024_.pdf

and it does look like the one someone was able to release early so hats off to their sleuthing.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing